Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

NCT06330896 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT06330896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06330896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing
Lead sponsor
Siriraj Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2024
Completion date
April 1, 2028
Enrollment
498 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell disorder